This Page Intentionally Left Blank - Int Medical

Special case:
n refractory pain: opioids (e.g. morphine initial dose 4–6 mg IV, then titrate)
in the ED, followed by outpatient referral for consideration of instituting
hormonal therapy
References
Dysmenorrhea 195
1. Allais G, Acuto G, Cabarrocas X, et al. Efficacy and tolerability of almotriptan
versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci.
2006;27(Suppl 2):S193–S197.
2. Ali Z, Burnett I, Eccles R, et al. Efficacy of a paracetamol and caffeine combination
in the treatment of the key symptoms of primary dysmenorrhoea. Curr
Med Res Opin. 2007;23(4):841–851.
3. Brogden RN, Heel RC, Speight TM, et al. Naproxen up to date: a review of its
pharmacological properties and therapeutic efficacy and use in rheumatic
diseases and pain states. Drugs. 1979;18(4):241–277.
4. Brooks P. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J
Med. 1998;104(Suppl 3A):9S–13S; discussion 21S–22S.
5. Budoff PW. Antiprostaglandins for primary dysmenorrhea. JAMA. 1981;246
(22):2576–2577.
6. Budoff PW. Mefenamic acid for dysmenorrhea in patients with intrauterine
devices. JAMA. 1979;242(7):616–617.
7. Budoff PW. Use of mefenamic acid in the treatment of primary dysmenorrhea.
JAMA. 1979;241(25):2713–2716.
8. Buppasiri P, Tangmanowutikul S, Yoosuk W. Randomized controlled trial of
mefenamic acid vs paracervical block for relief of pain for outpatient uterine
curettage. J Med Assoc Thai. 2005;88(7):881–885.
9. Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory
drugs for primary dysmenorrhoea. Cochrane Database Syst Rev. 2003(4):
CD001751.
10. Moore N. Diclofenac potassium 12.5 mg tablets for mild to moderate pain and
fever: a review of its pharmacology, clinical efficacy and safety. Clin Drug
Invest. 2007;27(3):163–195.
11. Anonymous. [New indication for selective COX-2 inhibitors. Now also
approve for acute pain.] MMW Fortschr Med. 2002;144(10):62.